LOUISE W. FLANAGAN, District Judge.
These consolidated cases involving violations of federal securities laws come now before the court on defendants' motion to dismiss plaintiffs' amended consolidated complaint for failure to state a claim pursuant to Federal Rule of Civil Procedure 12(b)(6) (DE 76). Lead plaintiff LifeWise Family Financial Security, Inc. ("LifeWise") filed its response in opposition to the motion, and defendants replied. In this posture, the issues presented are ripe for ruling. For the reasons that follow, defendants' motion is granted.
Plaintiffs commenced the instant actions on November 21, 2017 and November 28, 2017, respectively, alleging defendants violated of Securities Exchange Act of 1934 ("Exchange Act"), §§ 10(b) and 20(a), and applicable regulations by making fraudulent misrepresentations and omissions to investors in defendant Triangle Capital Corporation ("Triangle"). Plaintiffs seek to certify a class action on behalf of all purchasers of defendant Triangle's common stock, and seek damages, costs, attorney's fees, and other relief.
On January 12, 2018, the United States District Court for the Southern District of New York transferred
On April 10, 2018, plaintiff Lifewise served a consolidated amended complaint against defendants Triangle Capital, Garland S. Tucker, III ("Tucker"), Steven C. Lilly ("Lilly"), and E. Ashton Poole ("Poole"), together with an exhibit listing alleged false or misleading statements (DE 69-1). On May 25, 2018, defendants filed the instant motion to dismiss for failure to state a claim. Defendants argue that plaintiffs fail to plead an actionable misstatement or omission, plaintiffs fail to plead falsity with particularity, and plaintiffs have failed to allege facts which raise a strong inference of scienter. In support of the motion, defendants rely upon a supporting declaration and several exhibits, including transcripts of investor calls and investor presentations, press releases, and Forms 10-K and 10-Q. Reference is made to defendants' index of exhibits submitted for the court's consideration, lodged on the docket at (DE 78-1),
Lead plaintiff LifeWise responded in opposition to the motion. Lead plaintiff LifeWise argues that the complaint alleges several different types of false material misstatements and omissions by defendants that are actionable, and that the complaint adequately alleges scienter. Defendants replied by arguing plaintiffs mischaracterized their own allegations, and reasserted prior arguments regarding the absence of a material act or omission, falsity, or scienter on the face of plaintiffs' complaint.
The facts alleged in the complaint
Mezzanine financing is a hybrid of debt and equity financing that provides the lender with the ability to convert their financing to an ownership or equity interest in the borrowing company in the case of default. (
By approximately 2014, the mezzanine finance market began to experience some erosion due to the emergence of "unitranche" lending. (Compl. ¶ 26). Unitranche lending provided a hybrid security combining senior and subordinated debt in to one package with a blended rate and less risk. (
Plaintiffs allege that defendants misled the market with respect to the quality of the underwriting and investment controls and the quality of its 2014 and 2015 investments in order to continue to chase high end yields with lesser quality opportunities. (
On May 7, 2014, defendant Triangle issued a press release and Form 10-Q announcing financial results for the first quarter of2014, and defendant Tucker stated in the press release "we believe the lower middle market is poised to provide attractive investment opportunities during the balance of 2014." (
On August 6, 2014, defendant Triangle issued a press release and filed its Form 10-Q to announce its financial results for the second quarter of 2014, and defendant Tucker stated in the press release that "the second quarter of 2014 was robust on all fronts . . . [a]gain it is an exciting time for Triangle and it gives me great pleasure to be able to share such good news with our investors." (Compl. ¶ 38; 2014 Q2 Form 10-Q (DE 78-6)). On August 7, 2014, defendant Triangle held an earnings call with analysts and investors, where defendant Lilly stated that "we have taken advantage of what we perceived to be high-quality investment opportunities at attractive price points." (Compl. ¶ 39; 2014 Q2 Earnings Call (DE 78-7) at 4).
On November 5, 2014, defendant Triangle issued a press release and filed its Form 10-Q announcing the company's financial results for the third quarter of 2014. (Compl. ¶ 41; 2014 Q3 Press Release (DE 78-9) at 7; 2014 Q3 Form 10-Q (DE 78-8)). On November 6, 2014, defendant Triangle held its quarterly earnings call. (Compl. ¶ 42; 2014 Q3 Earnings Call (DE 78-10)). In that call, defendant Tucker stated "[w]e are pleased that the origination portion of our business is operating so well. Our investment pipeline has been robust all year. . . ." (Compl. ¶ 42; 2014 Q3 Earnings Call (DE 78-10) at 3). Defendant Poole also stated that, with respect to the amount of opportunities coming in the door and the opportunities that defendant Triangle chose to pursue, "I can safely say that our pipeline is healthy." (Compl. ¶ 42; 2014 Q3 Earnings Call (DE 78-10) at 8).
On March 2, 2015, defendant Triangle issued a press release and filed its Form 10-K, announcing financial results for the fourth quarter and full year of 2014. (Compl. ¶¶ 44, 46; 2014 Q4 Press Release (DE 78-12); 2014 Form 10-K (DE 78-11)). In the press release, defendant Tucker stated that the fourth quarter represented a "strong end of the year" and stated that defendant Triangle was "pleased with the quality of our investment portfolio, the strength of our balance sheet, and the opportunities we see across the lower middle market." (Compl. ¶ 45; 2014 Q4 Press Release (DE 78-12) at 7). Defendant Triangle's Form 10-K represented that "the financing market for lower middle market companies" was "underserved, providing [the Company] with greater investment opportunities." (Compl. ¶ 46; 2014 Form 10-K (DE 78-11)). That same day, defendant Triangle hosted an earnings call with analysts and investors, reviewing financial results for the fourth quarter and end of year 2014. (Compl. ¶ 48; 2014 Q4 Earnings Call (DE 78-13)). Defendants emphasized the quality of their investments and review process. (Compl. ¶ 48; 2014 Q4 Earnings Call (DE 78-13)). At one point, defendant Poole specifically stated "we will continue to remain focused on quality versus quantity in terms of new investment activity." (Compl. ¶ 49; 2014 Q4 Earnings Call (DE 78-13) at 5).
The 2014 Form 10-K also detailed defendant Triangle's investment process, explaining that for underwriting and approval, the defendant Triangle's investment committee would obtain due diligence from the underwriting team, request additional due diligence if necessary, and "approve the proposed investment by affirmative vote from a majority of the investment committee members" before proceeding with any investment. (
On May 6, 2015, defendant Triangle issued a press release and filed its Form 10-Q, announcing its financial results for the first quarter of 2015. (Compl. ¶ 51; 2015 Q1 Press Release (DE 78-15); 2015 Q1 Form 10-Q (DE 78-14)). In the press release, defendant Tucker stated "[w]e remain confident in both the overall quality of our investment portfolio and the investment opportunities in the lower middle market for the remainder of 2015." (Compl. ¶ 51; 2015 Q1 Press Release (DE 78-15) at 8). On May 7, 2015, defendant Triangle held its quarterly earnings call. (Compl. ¶ 52; 2015 Q1 Earnings Call (DE 78-16)). Defendant Poole stated that he and management felt "very good" about defendant Triangle's new investments, and defendant Lilly stated "quality over quantity. . . . that's what we try to focus on and always have and I think that would be most — biggest guide post as we move forward." (Compl. ¶ 52; 2015 Q1 Earnings Call (DE 78-16) at 11).
On August 5, 2015, defendant Triangle issued a press release and filed its Form 10-Q for the second quarter of 2015. (Compl. ¶ 54; 2015 Q2 Press Release (DE 78-18); 2015 Q2 Form 10-Q (DE 78-17)). On August 6, 2017, defendant Triangle held its quarterly earnings call. (Compl. ¶ 55; 2015 Q2 Earnings Call (DE 78-19)). Defendant Tucker stated "we believe a steady unwavering focus on appropriate risk adjusted returns is the best method of producing above average, long term results." (Compl. ¶ 55; 2015 Q2 Earnings Call (DE 78-19) at 3). Defendant Lilly also said "we're trying to find the best risk adjusted returns we can." (Compl. ¶ 55; Q2 Earnings Call (DE 78-19) at 10).
On November 4, 2015, defendant Triangle issued a press release and filed its Form 10-Q for the third quarter of 2015. (Compl. ¶¶ 57, 58; 2015 Q3 Press Release (DE 78-21); 2015 Q1 Form 10-Q (DE 78-20)). In the press release, defendant Tucker stated "we were able to originate a record level of new investments in high quality companies during the quarter" and that defendant Triangle was able to "take advantage of what we perceive to be an opportune time in the investing market." (Compl. ¶ 58; 2015 Q3 Press Release (DE 78-21) at 6). On November 5, 2015, defendant Triangle hosted its quarterly earnings call. (Compl. ¶ 59; 2015 Q3 Earnings Call (DE 78-22)). Defendants emphasized the robustness of defendant Triangle's underwriting procedures, with defendant Tucker stating "I believe Triangle has successfully navigated this rough [p]atch with the same measure of discipline and focus. . . ." (
On February 3, 2016, defendant Triangle announced that defendant Poole would take over as CEO, while defendant Tucker would continue to serve as Chairman of the Board. (Compl. ¶ 62). Following defendant Poole becoming CEO, defendant Triangle implemental a new operational plan, called TCAP 2.0, which it claimed would promote open communication, cross-functional alignment, and increased accountability. (
On February 24, 2016, defendant Triangle issued a press release and filed its Form 10-K, announcing financial results for the fourth quarter and full year of 2015. (
On May 4, 2016, defendant Triangle issued a press release and filed its Form 10-Q, announcing financial results for the first quarter of 2016. (Compl. ¶ 72; 2016 Q1 Form 10-Q (DE 79-3). On May 5, 2016, defendant Triangle hosted its quarterly earnings call. (Compl. ¶ 73). On the call, defendant Poole stated that yield compressions impacted defendant Triangle's "market pricing and the weighted average yield of our investment portfolio." (
On July 29, 2016, defendant Triangle issued a press release announcing that it closed an underwritten public officer of common stock, which netted approximately $119.6 million in proceeds. (
On August 3, 2016, defendant Triangle issued a press release and filed its Form 10-Q, announcing its financial results for the second quarter of 2016. (
On October 18, 2016, defendant Triangle announced that Brent P.W. Burgess ("Burgess") was resigning from his positions as Chief Investment Officer ("CIO") and director. (Compl. ¶ 80). On November 2, 2016, defendant Triangle issued a press release and filed its Form 10-Q, announcing financial results for the third quarter of 2016. (
On February 22, 2017, defendant Triangle issued a press release and filed its Form 10-K, announcing financial results for the fourth quarter and full year of 2016. (Compl. ¶¶ 85, 86; 2016 Form 10-K (DE 79-9)). The 2016 Form 10-K also detailed defendant Triangle's investment process, portfolio management and investment monitoring processes. (Compl. ¶ 86; 2016 Form 10-K (DE 79-9) at 7-9). Defendant Triangle's 2016 Form 10-K also described the company's internal process for rating investments. (Compl. ¶ 87; 2016 Form 10-K (DE 79-9) at 10). On February 23, 2017, defendant Triangle held its quarterly earnings call to discuss financial results for the fourth quarter of 2016. (Compl. ¶ 89; 2016 Q4 Earnings Call (DE 79-10)). Defendant Poole, commenting on the new structure for underwriting and risk assessment, stated that he put in place "multiple points of what I would call veto authority for transactions, wether in the original inception mode, in contemplation mode, all the way through documentation modes and ultimately through final approval modes." (Compl. ¶ 90; 2016 Q4 Earnings Call (DE 79-10) at 7). Defendant Poole elaborated, stating "at each point of the process, unlike before, certain individuals within the organization will have full veto rights on a transaction. . . ." (Compl. ¶ 90; 2016 Q4 Earnings Call (DE 79-10) at 7).
On February 28, 2017, defendant Triangle raised approximately $132 million in equity growth capital. (Compl. ¶ 91). On May 1, 2017, defendant Triangle announced it amended its senior credit facility by $135 million to a total of $435 million, with a final maturity date of April 30, 2022. (
On May 3, 2017, defendant Triangle issued a press release and filed its From 10-Q, announcing financial results for the first quarter of 2017. (
On June 22, 2017, defendant Triangle hosted its 8th Annual Analyst and Investor Meeting. (
On August 2, 2017, defendant Triangle issued a press release announcing its financial results for the second quarter of 2017. (Compl. ¶ 98; 2017 Q2 Press Release (DE 79-13)). On August 3, 2017, defendant Triangle held its quarterly earnings call, were defendants were asked several questions by investors and analysts raising concerns about defendant Triangle's 2014 and 2015 investments. (Compl. ¶ 101; 2017 Q2 Earnings Call (DE 79-15)). During the call, defendant Lilly stated that it was likely that only two of the five portfolio companies carrying below 80% of cost would go on non-accrual in the next two to four quarters, and only one that carried above 80% of cost "might go in non-accrual" during the same timeframe. (Compl. ¶ 101; 2017 Q2 Earnings Call (DE 79-15) at 6). Defendant Poole added that defendant Triangle has recently improved its credit monitoring capabilities to identify trouble areas in its portfolio. (
On November 1, 2017, defendant Triangle issued a press release announcing its financial results for the third quarter of 2017. (Compl. ¶ 107; 2017 Q3 Press Release (DE 79-17)). In this announcement, defendant Triangle announced that it had placed seven new investments on non-accrual status during the quarter. (Compl. ¶ 107; 2017 Q3 Press Release (DE 79-17)). On November 2, 2017, defendant Triangle held its quarterly earnings call. (Compl. ¶ 108; 2017 Q3 Earnings Call (DE 79-18)). During the call, defendant Poole, reflecting on the failure of defendant Triangle's investment strategy, explained to analysts and investors that defendant Triangle's investment professionals had advised defendant Tucker to begin moving away from mezzanine structures and into lower-yielding but more secure second lien, unitranche, and senior structures. (Compl. ¶ 108; 2017 Q3 Earnings Call (DE 79-18) at 3-4). Defendant Poole then explained that defendant Triangle had adhered "to a majority-focused mezzanine investment strategy," and "in the process of doing so, we added incremental exposure to a number of riskier credits." (Compl. ¶ 108; 2017 Q3 Earnings Call (DE 79-18) at 3-4). Defendant Poole stated that "at this point we acknowledge that as a firm we are being held back primarily by our 2014 and 2015 investment vintages." (Compl. ¶ 108; 2017 Q3 Earnings Call (DE 79-18) at 3-4).
Regarding the origination process in 2014 and 2015, defendant Poole stated that "the origination teams were being directed to focus on the mezzanine opportunities. So, in some respect, the self selection at that point was an embedded credit decision." (Compl. ¶ 110; 2017 Q3 Earnings Call (DE 79-18) at 12).
Additional facts pertinent to the instant motion will be discussed below.
To survive a motion to dismiss" under Rule 12(b)(6), "a complaint must contain sufficient factual matter, accepted as true, to `state a claim to relief that is plausible on its face.'"
Ordinarily, a plaintiff need only make "a short and plain statement of the claim showing that the pleader is entitled to relief." Fed. R. Civ. P. 8(a)(2). However, Rule 9(b) creates an exception to this liberal pleading standard and requires that "[i]n alleging fraud or mistake, a party must state with particularity the circumstances constituting fraud or mistake." Fed. R. Civ. P. 9(b). "This heightened pleading requirement serves to protect defendants' reputations from baseless accusations, eliminate meritless suits brought only to extract a settlement, discourage fishing expeditions, and provide defendants with enough information about a plaintiff's allegations to mount a defense."
"[T]he inconsistent application and interpretation of Rule 9(b) and other abuses in securities cases prompted Congress to enact the PSLRA [Private Securities Litigation Reform Act]."
Section 10(b) of the Exchange Act, makes it unlawful "[t]o use or employ, in connection with the purchase or sale of any security . . . any manipulative or deceptive device or contrivance in contravention of such rules and regulations as the Commission may prescribe." 15 U.S.C. § 78j(b). Section 10(b) is implemented by Rule 10b-5, which makes it unlawful "[t]o employ any device, scheme or artifice to defraud[;] [t]o make any untrue statement of a material fact or to omit to state a material fact necessary in order to make the statements made . . . not misleading, or[;] [t]o engage in any act, practice, or course of business which operates or would operate as a fraud or deceit upon any person." 17 C.F.R. § 240.10b-5. Section 10(b) provides an implied private right of action, and the plaintiff in such an action "must prove (1) a material misrepresentation or omission by the defendant; (2) scienter; (3) a connection between the misrepresentation or omission and the purchase or sale of a security; (4) reliance upon the misrepresentation or omission; (5) economic loss; and (6) loss causation."
Section 20(a) of the Exchange Act imposes liability on "every person who, directly or indirectly, controls any person liable under any provision of [the Exchange Act]" . . . "to the same extent as such controlled person" . . . "unless the controlling person acted in good faith and did not directly or indirectly induce the act or acts constituting the violation or cause of action." 15 U.S.C. § 78t(a). "Section 20(a) is the vehicle for imposing liability on control persons. The liability of a control person under section 20(a) is derivative of—and dependent upon—liability of a controlled person under section 10(b)."
The first element necessary to state a claim under Rule 10b-5 is "a material misrepresentation or omission by the defendant."
In addition to establishing that a statement or omission is false, a statement or omission must be material in order to be actionable. A "fact stated or omitted is material if there is a substantial likelihood that a reasonable purchaser or seller of a security (1) would consider the fact important in deciding whether to buy or sell the security or (2) would have viewed the total mix of information made available to be significantly altered by disclosure of the fact."
With this legal framework in mind, the court turns to the allegations set forth in the complaint. Lead plaintiff LifeWise alleges defendants engaged in four different types of material false statements and omissions: 1) defendants touted the quality of their investments, but failed to reveal that defendants were continuing to pursue mezzanine finance opportunities over the advice of their investment professionals; 2) defendants continuously emphasized the adequacy of defendant Triangle's origination practices, when defendants knew the company was chasing high-yield investments from lower-quality investment opportunities; 3) defendants represented the company's investment committee was responsible for approving investments, but defendant Tucker was solely responsible for approval and veto of proposed investments; and 4) defendants did not properly discolse the true extent of the issues caused by defendant Triangles 2014 and 2015 investments until after necessary financing had been obtained. The court addresses each set of alleged false statements in turn.
Plaintiff LifeWise first contends that defendants made false factual statements and omissions by touting the quality of defendant Triangle's investments during 2014 and 2015, but failed to disclose that investment professionals had recommended defendant Triangle should shift away from mezzanine products to lower risk unitranche products that would offer a lower rate of return. (Pl. Resp. (DE 83) at 18;
In 2014 and 2015, defendants made a variety of different statements expressing that they believed that they were making quality investments. (
Most of these statements are forward looking and encompass discussions of defendant Triangle's operations, future economic performance, and the assumptions underlying each of these items.
Defendants remaining statements in 2014 and 2015 regarding the quality of the investments in those vintages are opinion statements. (
In order for such opinions about the quality of investments to be actionable, the statements must be "false, disbelieved by its maker, and related to matters of fact which can be verified by objective evidence."
Lead plaintiff LifeWise's reliance solely on defendant Poole's statements is insufficient to adequately plead that defendants disbelieved their statements that defendant Triangle's investments were quality investments. It is not clear from defendant Poole's statement who these investment professionals are, or when these recommendations were made. (
Even setting aside the obvious deficiency presented by plaintiffs' complaint, the pleadings as alleged do not plausibly show that defendants disbelieved that their investments were quality investments in relation to unitranche investments. For example, in the March 2, 2015 earnings call with investors, defendant Tucker stated that
(2014 Q4 Earnings Call (DE 79-13) at 15). Earlier in that same call, defendant Poole discussed how defendant Triangle had made additional unitranche deals during the fourth quarter of 2014. (2014 Q4 Earnings Call (DE 79-13) at 12). Defendants made similar comments on other earnings calls with investors, discussing defendant Triangle's investment strategy as between mezzanine and unitranche opportunities, and emphasizing that they believed it was important to secure the most attractive investment for stockholders.
Such comments acknowledge that, during 2014 and 2015, defendants had considered the mix of unitranche and mezzanine debt in its portfolio, determined that defendant Triangle's best investment approach was to undertake some unitranche deals but remain focused on mezzanine finance, and disclosed such strategy to its investors. The court cannot reasonably infer from defendants' comments, absent additional facts, that defendants disbelieved that they were making quality investments.
Consequently, plaintiffs fail to plead sufficient, particularized facts to plausibly show defendants' statements regarding the quality of defendant Triangle's investments were false.
Plaintiff LifeWise argues that defendants misrepresented the quality of defendant Triangle's origination practices, such as focusing on quality over quantity and growing its investment portfolio in a reasonable manner, when really defendants alleged knew that defendant Triangle was "chasing high-yield investments from lower quality investment opportunities." (Pl. Resp. (DE 83) at 18).
Defendants made several statements emphasizing that defendant Triangle focuses on quality of investments rather than quantity. (
Plaintiffs also seize on defendant Poole's initiation of TCAP 2.0 as an indication that defendants did not believe that their origination process was adequate before such changes. For example, defendant Poole stated on November 3, 2016 that "maybe there were fewer checks and balances in the investment process" in 2014 and 2015, and "so what I've tried to do is implement a more fulsome up front, check and balance process that will hopefully on the margin continue to tighten up that underwriting process and improve the investment results." (
Defendants' statements in 2016 and 2017 regarding origination are driven by hindsight and fail to show that defendants believed their origination process was inadequate when making contemporaneous opinion statements about the quality of defendant Triangle's origination process for its 2014 and 2015 investment vintages. (
Moreover, plaintiffs fail to plead sufficient facts to plausibly show a fraudulent omission regarding defendants' strategy to prioritize high yield investments. (
For these reasons, the complaint fails to plead with sufficient specificity facts that show defendants believed their origination process was inadequate when making contemporaneous statements about originating its 2014 and 2015 investments. Thus defendants cannot be said to have made a material false statement or omission as to its origination process in 2014 and 2015.
Plaintiff LifeWise's third alleged set of alleged misrepresentations stems from defendants' representations concerning the final approval of investments at defendant Triangle. Specifically, plaintiff LifeWise alleges that defendants represented that the investment committee had the responsibility for final approval or rejection of investments in their 2014 Form 10-K and other disclosures, but that in actual practice "[d]efendant Tucker was solely responsible for approval and veto of proposed investments." (Pl. Resp. (DE 83) at 18).
Defendant Triangle's Forms 10-K for 2014 and 2015
The only specific mention in all of the complaint regarding defendant Tucker's relationship to the investment committee during his tenure as CEO was at the 8th Annual Analyst and Investor Meeting in 2017. (
Defendant Triangle's disclosures and presentations on the investment process are consistent that the investment committee approved investments by simple majority vote. (2014 Form 10-K (DE 78-11) at 7, 8; 2015 Form 10-K (DE 78-23) at 7, 8; 2017 Investor Meeting (DE 79-12) at 5). Although defendant Triangle stated in its investor meeting presentation that defendant Tucker chaired the investment committee, and the committee "looked to [defendant Tucker] for `approval' or `rejection,'" those statements do not establish a reasonable inference that defendant Tucker had an absolute veto over the investment committee or could unilaterally approve investments without a majority vote of the committee. (
For these reasons, plaintiff LifeWise has failed to plausibly show that defendant Triangle made a false statement or omission regarding defendant Tucker's role in the final selection of investments by defendant Triangle's investment committee in 2014 and 2015.
Finally, plaintiff LifeWise argues that "[d]efendants did not properly disclose the true extent of the issues caused by Triangle's 2014 and 2015 investments, [and] their likelihood of nonaccrual. . . until after the necessary financing was obtained."
On August 3, 2017, defendant Lilly stated during his discussion of companies carried below 80% of costs that "there are five of those accounts I think in the portfolio today. And I think from a prior experience standpoint, we would say the average is probably two of those five in the next same time period two to three, four quarters" would go on nonaccrual. (Compl. ¶ 101; 2017 Q2 Earnings Call (DE 79-15) at 6). This was the first time that defendants publicly acknowledged that several 2014 and 2015 investments were likely to go on nonaccrual. Plaintiffs offer no allegations to argue that this projection by defendant Lilly was a false statement, and in any event, such a forward looking statement about the likelihood of nonaccrual of investments is protected by the bespeaks caution doctrine, since defendant Lilly identified the statement as a projection and cautioned against relying on it.
Although the complaint raises many broad allegations that defendants knew the 2014 and 2015 investment vintages had problems, (
Additionally, defendants statements are not made false by the omission of information concerning the state of each of the investments placed on nonaccrual, because defendant Triangle disclosed to its investors on a quarterly basis the cost and fair value status of all the investments eventually placed on nonaccrual status. (
Based on the foregoing, plaintiffs' complaint is dismissed without prejudice for failure to state a claim. Plaintiff LifeWise is allowed to file a motion to amend, together with proposed second consolidated amended complaint correcting the deficiencies discussed herein, within 21 days from date of entry of this order.
For the foregoing reasons, the court GRANTS defendants' motion to dismiss for failure to state a claim (DE 76). Plaintiffs' complaint is DISMISSED WITHOUT PREJUDICE. Plaintiff LifeWise is ALLOWED to file a motion to amend, together with proposed second consolidated amended complaint correcting the deficiencies discussed herein, within 21 days from date of entry of this order. Should plaintiff LifeWise fail to file an amended complaint by the deadline set herein, the clerk is DIRECTED to close these consolidated cases.
SO ORDERED.